LeMaitre Vascular, Inc.
LMAT · NASDAQ
9/30/2025 | 6/30/2025 | 3/31/2025 | 12/31/2024 | |
|---|---|---|---|---|
| Market Cap | $2 | $2 | $2 | $2 |
| - Cash | $0 | $0 | $0 | $0 |
| + Debt | $0 | $0 | $0 | $0 |
| Enterprise Value | $2 | $2 | $2 | $2 |
| Revenue | $0 | $0 | $0 | $0 |
| % Growth | -5% | 7.3% | 7.5% | – |
| Gross Profit | $0 | $0 | $0 | $0 |
| % Margin | 75.3% | 70% | 69.2% | 69.3% |
| EBITDA | $0 | $0 | $0 | $0 |
| % Margin | 43.4% | 34.3% | 30.2% | 36.2% |
| Net Income | $0 | $0 | $0 | $0 |
| % Margin | 28.4% | 21.5% | 18.4% | 20.1% |
| EPS Diluted | 0.75 | 0.6 | 0.48 | 0.49 |
| % Growth | 25% | 25% | -2% | – |
| Operating Cash Flow | $0 | $0 | $0 | $0 |
| Capital Expenditures | -$0 | -$0 | -$0 | -$0 |
| Free Cash Flow | $0 | $0 | $0 | $0 |